课题基金 / 基金详情

Hypoxia-selective inhibitors of DNA repair

Hypoxia-selective inhibitors of DNA repair
DNA 修复的缺氧选择性抑制剂
批准号：
376328
负责人：
Minchinton Andrew I
金额：
$18.9万
依托单位：
B.C. Cancer Research Centre (Vancouver)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-11-01 至 2020-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=376328&lang=en
关键词：
Dna Repair Drug Discovery Medicinal Chemistry Prodrugs Radiation Biology Radiosenstiziation Radiotherapy Targeting Hypoxia Tumour Hypoxia Tumour Microenvironment

项目摘要

项目成果

Minchinton Andrew I的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed work involves the development of a drug that will improve the effectiveness of radiation therapy. Since radiation therapy is used to treat about 50% of all cancers this drug could have very wide impact, improving cure rates as well as quality
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of clinical candidate hypoxia-activated DNA-PK inhibitors
FLASH radiotherapy - mechanisms and translational studies
Metabolic manipulation of hypoxia for improved radiotherapy response
Hypoxia-activated DNA repair inhibitors to improve cancer therapy
海外基金